omniture
上海药明生物技术有限公司 Wuxi Biologics

Latest News

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19

SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccin...

2021-03-16 16:30 2336

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility

WUXI, China, March 3, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company ...

2021-03-03 18:23 1629

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories

SHANGHAI, Feb. 25, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company wit...

2021-02-25 08:00 1702

The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics

* Greatly increase the company's current capacity to 90,000L and enable WuXi Biologics to initiat...

2021-02-09 08:25 1806

WuXi Biologics Receives GMP Certification from Brazil's ANVISA

* First company in China to receive GMP certification for the production of biologics from the U....

2020-12-28 17:50 1834

WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer

* The DS facility (MFG19) with 3x1000L perfusion and 6x2000L fed-batch capacity for vaccines and ...

2020-12-21 21:02 1844

Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation

MUNICH and SHANGHAI, Dec. 2, 2020 /PRNewswire/ -- Tubulis, WuXi STA and WuXi Biologics today announ...

2020-12-02 19:00 1818

WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou

HANGZHOU, China, Nov. 20, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global comp...

2020-11-20 16:30 1842

WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa

* Tadekinig alfa is a novel IL-18 binding protein in pivotal Phase 3 testing for orphan disease I...

2020-10-29 17:00 1944

WuXi Biologics Records Excellent Interim Results

Revenue Up 21.0% Y-o-Y to RMB1,944.1 Million Net Profit Up 62.6% to RMB730.7 Million Profit Attribut...

2020-08-18 00:51 2769

WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer

SHANGHAI and DUNDALK, Ireland, Aug. 6, 2020 /PRNewswire/ -- WuXi Vaccines, a global leading company...

2020-08-06 17:00 2694

WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor

SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with...

2020-08-04 17:00 2309

Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day

SHANGHAI, June 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company wit...

2020-06-19 17:56 1768

WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing

* One of few third-party biosafety testing providers certified by EMA GMP standards inChina even ...

2020-06-16 08:00 2292

WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States

CRANBURY, NJ and SHANGHAI, June 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a gl...

2020-06-09 08:00 1809

WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories

SHANGHAI and NEW YORK, May 28, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global...

2020-05-28 08:00 2047

WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States

SHANGHAI and WORCESTER, Mass., May 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), ...

2020-05-19 08:00 2415

WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform

SHANGHAI and HOUSTON, April 30, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a glob...

2020-04-30 19:00 1442

WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility

* First GMP facility in WuXi Biologics to use robotic aseptic filling line for biologics * Demo...

2020-04-28 08:00 1831

WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany

SHANGHAI and LEVERKUSEN, Germany, April 22, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269....

2020-04-22 08:00 1866